Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-10-14
- Lead Sponsor
- Neurogen Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT00834327
- Locations
- ๐บ๐ธ
Broward Research Group, Pembroke Pines, Florida, United States
๐บ๐ธGaylord Sleep Medicine, Wallingford, Connecticut, United States
๐บ๐ธGenova Clinical Research, Tuscon, Arizona, United States
Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
Phase 2
Terminated
- Conditions
- Early Parkinson Disease
- Interventions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2009-08-28
- Lead Sponsor
- Neurogen Corporation
- Target Recruit Count
- 9
- Registration Number
- NCT00809302
- Locations
- ๐บ๐ธ
LSU Health Science Center Shreveport (132), Shreveport, Louisiana, United States
๐บ๐ธBoston University (040), Boston, Massachusetts, United States
๐บ๐ธColorado Neurological Institute (052), Englewood, Colorado, United States
Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2008-07-22
- Lead Sponsor
- Neurogen Corporation
- Target Recruit Count
- 84
- Registration Number
- NCT00683436
- Locations
- ๐บ๐ธ
Neurotrials Research, Inc, Atlanta, Georgia, United States
๐บ๐ธTri-State Sleep Disorders Center, Cincinnati, Ohio, United States
๐บ๐ธSt. Luke's Hospital Sleep Medicine and Research Center, Chesterfield, Missouri, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath